Connect Pharma Limited
10098728
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/05/2025
total exemption full
Next accounts due
28/02/2027
Confirmation statement
Last: 01/04/2026
Due 15/04/2027
Industry
Officers
director · Since 01/06/2020
DIRECTOR
BRITISH · ENGLAND · Age 47
Also on 1 other board
director · Since 01/06/2020
DIRECTOR
BRITISH · ENGLAND · Age 41
Also on 19 other boards
Persons with Significant Control
Mr Joseph Cattee
British · England · Age 41
11, Manchester Road, Manchester, M28 3NS
Notified 01/06/2020
Mrs Anna Elizabeth Cattee
British · England · Age 40
11, Manchester Road, Manchester, M28 3NS
Notified 01/06/2020
Former PSCs
Mr Michael James Davis De Riz
Ceased 01/06/2020
Mr Peter Cattee
Ceased 01/06/2020
CompanyRankvs 11000+ SIC 46460 peers56
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/05/2024
Net Worth
£100
Balance sheet strength
Cash
£1.6M
Cash in the bank
Net Current Assets
£2.0M
Working capital
Current Assets
£2.3M
Current Liabilities
£254k
Fixed Assets
£121k
Debtors
£708k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 8.98 | — |
| 2023 | 5.98 | +£733k |
| 2022 | 7.23 | +£276k |
| 2021 | 3.48 | — |
| 2020 | 0.00 | — |
| 2018 | 1.00 | — |
Derived from filed accounts. Not audited figures.